BioInfra Life Science Inc. (XKON:266470)
South Korea · Delayed Price · Currency is KRW 109.00
0.00 (0.00%)
At close: Sep 11, 2026
BioInfra Life Science Market Cap
BioInfra Life Science has a market cap or net worth of 2.36 billion as of September 11, 2026. Its market cap has decreased by -42.02% in one year.
Market Cap
2.36B
Enterprise Value
n/a
Revenue
1.78B
Ranking
n/a
PE Ratio
n/a
Stock Price
109.00
ChartMarket Cap Chart
Since July 22, 2020, BioInfra Life Science's market cap has decreased from 57.13B to 2.36B, a decrease of -95.87%. That is a compound annual growth rate of -40.47%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 2.36B | -60.36% |
| Dec 30, 2025 | 5.96B | -33.89% |
| Dec 30, 2024 | 9.01B | 75.26% |
| Dec 28, 2023 | 5.14B | -65.89% |
| Dec 29, 2022 | 15.08B | -60.07% |
| Dec 30, 2021 | 37.76B | -10.67% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 22, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| RecensMedical | 105.38B |
| Corentec | 53.56B |
| DENTIS CO.,Ltd | 40.55B |
| Finemedix | 35.08B |
| Sanigen Co. | 29.96B |
| Genolution | 25.51B |
| TASCOM | 22.28B |
| Alpha AI | 10.45B |